ArticleClinical and molecular hepatology2026

Capturing systemic disease burden in MASLD: Toward integrated liver-kidney-cardiovascular economic models: Reply to correspondence on "Evaluating treatment response thresholds for cost-effective treatment in metabolic dysfunction-associated steatotic liver disease".

Anna Di Sessa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.